This site was designed with the
.com
website builder. Create your website today.
Start Now
  • Our Team

  • Our Portfolio

  • About Us

  • Contact Us

  • Dr. Paiva

  • Sean Finlayson

  • AliveCor

  • Altheus

  • Consano

  • Lifetone

  • Selexys

  • Ekips Technologies

  • ForHealth Technologies

  • Inoveon

  • InterGenetics

  • Zapaq

  • Otologics

  • CareATC

  • More

    Use tab to navigate through the menu items.

     OLSF III

    sway logo.png
    Sway

    Smartphone applications for cognitive testing

    Button
    Button
    Recuro Health

    An integrated digital health solution 

    Zero

    A mobile benefit plan manager

    RecuroHealth-logo-1000.png
    zero-logo.d692572e.png

     OLSF II

    Otologic Pharmaceutics

    Therapeutic solutions for hearing health

    Tetherex Pharmaceuticals

    Developing a treatment for Crohns Disease

    Tetherex

    AliveCor
    AliveCor

    A smartphone-enabled electrocardiogram (ECG) device

    Altheus Therapeutics
    Altheus Therapeutics

    Developing a treatment for ulcerative colitis

    Consano Healthcare
    Consano Healthcare

    Managed Therapy Services, Staffing & Clinics

    Lifetone Technology
    Lifetone Technology

    A smoke alarm for the hearing impaired

    Selexys Pharmaceuticals (acquired by Novartis)
    Selexys Pharmaceuticals (acquired by Novartis)

    Developing a treatment for sickle cell disease

    Care ATC (acquired by Care ATC)

    Managed on-site and near-site medical clinics

     OLSF I

    Ekips Technologies
    Ekips Technologies

    Develops innovative laser-based sensors

    ForHealth Technologies (acquried by Baxa Corporation)
    ForHealth Technologies (acquried by Baxa Corporation)

    Medication administration software and services

    Inoveon (acquired by iFa Systems)
    Inoveon (acquired by iFa Systems)

    Delivers solutions to diseases affecting the eye

    InterGenetics
    InterGenetics

    Molecular diagnostics and therapies for cancer

    Zapaq (acquired through recapitalization)
    Zapaq (acquired through recapitalization)

    A drug discovery and development company

    The Oklahoma Life Science Fund  |  T 918.625.3160  |  www.olsfventures.com  |  © 2013 by The Oklahoma Life Science Fund

    • facebook
    • LinkedIn Square